2022 - Research.com Best Scientist Award
2006 - Member of the National Academy of Sciences
His primary scientific interests are in Vascular endothelial growth factor, Vascular endothelial growth factor A, Angiogenesis, Cancer research and Internal medicine. His Vascular endothelial growth factor research is multidisciplinary, relying on both Endothelial stem cell, Molecular biology, Growth factor and Immunology. His Vascular endothelial growth factor A study incorporates themes from Endothelium and Cell biology.
Napoleone Ferrara specializes in Angiogenesis, namely Neovascularization. His Cancer research research includes elements of Cancer, Colorectal cancer, Neoplasm, Bevacizumab and Monoclonal antibody. The concepts of his Internal medicine study are interwoven with issues in Endocrinology, Internal iliac artery and Oncology.
Napoleone Ferrara mainly focuses on Vascular endothelial growth factor, Angiogenesis, Cancer research, Vascular endothelial growth factor A and Internal medicine. His Vascular endothelial growth factor study integrates concerns from other disciplines, such as Endothelial stem cell, Receptor, Growth factor, Molecular biology and Cell biology. In his study, Bevacizumab is strongly linked to Immunology, which falls under the umbrella field of Angiogenesis.
In his research, Nucleic acid is intimately related to Antibody, which falls under the overarching field of Cancer research. His Vascular endothelial growth factor A research is multidisciplinary, incorporating elements of Endothelium and Vascular permeability. His Internal medicine research is multidisciplinary, relying on both Endocrinology and Oncology.
Napoleone Ferrara mostly deals with Angiogenesis, Cancer research, Vascular endothelial growth factor, Cell biology and Immunology. Napoleone Ferrara combines subjects such as Vascular endothelial growth factor A, Endothelial stem cell, Paracrine signalling and Pharmacology with his study of Angiogenesis. His Vascular endothelial growth factor A research is within the category of Internal medicine.
His studies in Cancer research integrate themes in fields like Inflammation, Antibody, Metastasis and In vivo. When carried out as part of a general Vascular endothelial growth factor research project, his work on Vascular endothelial growth factor B is frequently linked to work in Protein phosphorylation, therefore connecting diverse disciplines of study. His Immunology research integrates issues from Cancer and MAPK/ERK pathway.
The scientist’s investigation covers issues in Angiogenesis, Cell biology, Immunology, Vascular endothelial growth factor A and Neovascularization. His Angiogenesis research is multidisciplinary, incorporating elements of Autocrine signalling, Paracrine signalling, Vasculogenesis, Pharmacology and In vivo. The Cell biology study combines topics in areas such as Endocrinology, Mural cell, Vascular endothelial growth factor, Internal medicine and Sprouting angiogenesis.
His work in Vascular endothelial growth factor covers topics such as Signal transduction which are related to areas like Somatic cell. His Immunology research includes elements of Cancer and Cancer research. His Vascular endothelial growth factor A study incorporates themes from Bevacizumab, Ranibizumab, Retina and Retinal.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
BEVACIZUMAB PLUS IRINOTECAN, FLUOROURACIL, AND LEUCOVORIN FOR METASTATIC COLORECTAL CANCER
Herbert Hurwitz;Louis Fehrenbacher;William Novotny;Thomas Cartwright.
The New England Journal of Medicine (2004)
The biology of VEGF and its receptors.
Napoleone Ferrara;Hans-Peter Gerber;Jennifer LeCouter.
Nature Medicine (2003)
Vascular endothelial growth factor is a secreted angiogenic mitogen
David W. Leung;George Cachianes;Wun-Jing Kuang;David V. Goeddel.
Science (1989)
THE BIOLOGY OF VASCULAR ENDOTHELIAL GROWTH FACTOR
Napoleone Ferrara;Terri Davis-Smyth.
Endocrine Reviews (1997)
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
K. Jin Kim;Bing Li;Jane Winer;Mark Armanini.
Nature (1993)
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.
Napoleone Ferrara;Karen Carver-Moore;Helen Chen;Mary Dowd.
Nature (1996)
Vascular endothelial growth factor: basic science and clinical progress.
Napoleone Ferrara.
Endocrine Reviews (2004)
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
Napoleone Ferrara;William J. Henzel.
Biochemical and Biophysical Research Communications (1989)
Angiogenesis as a therapeutic target
Napoleone Ferrara;Robert S. Kerbel.
Nature (2005)
Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway REQUIREMENT FOR Flk-1/KDR ACTIVATION
Hans Peter Gerber;Amy McMurtrey;Joe Kowalski;Minhong Yan.
Journal of Biological Chemistry (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Genentech
Genentech
Genentech
Genentech
Genentech
University of California, San Francisco
Shanghai Jiao Tong University
Genentech
Tufts University
Cincinnati Children's Hospital Medical Center
University of Missouri–Kansas City
Nankai University
United States Naval Research Laboratory
Soochow University
Columbia University
MIT
IBM (United States)
Smithsonian Tropical Research Institute
University of Franche-Comté
Murdoch University
Institut Jean-Pierre Bourgin
University of British Columbia
University of Minnesota
Nagoya University
Boston Children's Hospital
Boston University